ChemoCentryx (NASDAQ:CCXI) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

ChemoCentryx beat estimated earnings by 10.2%, reporting an EPS of $-0.44 versus an estimate of $-0.49.

Revenue was up $9.95 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.25 which was followed by a 11.13% increase in the share price the next day.

Here's a look at ChemoCentryx's past performance:

To track all earnings releases for ChemoCentryx visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.